文献速递慢性肾脏病血液净化与透析

CKD患者维生素补充:值得服药负担吗?

Vitamin Supplement Use in Patients With CKD: Worth the Pill Burden?
PubMed 文献 · Am J Kidney Dis · 2023-10-24

本文综述了慢性肾脏病(CKD)及透析患者维生素缺乏的风险、检测局限性和补充证据。截至2016年系统综述后无随机试验支持任何维生素补充对肾脏、心血管或患者中心结局的获益;水溶性维生素补充应个体化,营养性维生素D缺乏应纠正,不推荐常规补充维生素A和E,所有CKD患者应定期评估膳食摄入并鼓励通过天然食物获取维生素。

要点

  • 无随机试验支持任何维生素补充改善CKD患者肾脏、心血管或患者中心结局。
  • 水溶性维生素补充应个体化,考虑膳食摄入、营养状态、缺乏风险、CKD分期、合并症和透析丢失。
  • 营养性维生素D缺乏应纠正,剂量和剂型需个体化;不推荐常规补充维生素A和E。

核心结论

  • 截至2016年系统综述后,无随机试验支持任何维生素补充对CKD患者肾脏、心血管或患者中心结局的获益。

研究设计与样本

  • 本文为综述,总结了2016年系统综述之后的近期证据,用于KDOQI 2020营养指南更新。

主要发现

  • CKD患者包括透析患者因厌食、膳食摄入差、蛋白质能量消耗、限制饮食、透析丢失或日照不足而维生素D缺乏风险增加。
  • 大多数维生素缺乏的临床表现通常轻微或未被发现。
  • 除叶酸、B12和25-羟基维生素D外,大多数维生素不进行循环水平检测,因为检测可能不可用或昂贵且不总是与身体储备相关。

关键数值与推荐

  • 水溶性维生素补充决策应个体化,考虑患者膳食摄入、营养状态、维生素缺乏/不足风险、CKD分期、合并症状态和透析丢失。
  • 营养性维生素D缺乏应纠正,但补充剂量和剂型需个体化,考虑25-羟基维生素D缺乏程度、甲状旁腺激素水平、CKD分期和当地剂型。
  • 不推荐常规补充维生素A和E,因潜在毒性。
  • 所有CKD患者应定期评估膳食摄入,旨在通过天然食物来源和包含维生素密集食物的健康饮食模式获取各种维生素。

临床怎么用

  • 水溶性维生素补充应基于患者膳食摄入、营养状态、缺乏风险、CKD分期、合并症和透析丢失个体化决策。
  • 营养性维生素D缺乏应纠正,剂量和剂型根据25-羟基维生素D缺乏程度、甲状旁腺激素水平、CKD分期和当地剂型个体化。
  • 不常规补充维生素A和E;所有CKD患者定期评估膳食摄入并鼓励通过天然食物获取维生素。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

All vitamins play essential roles in various aspects of body function and systems. Patients with chronic kidney disease (CKD), including those receiving dialysis, may be at increased risk of developing vitamin deficiencies due to anorexia, poor dietary intake, protein energy wasting, restricted diet, dialysis loss, or inadequate sun exposure for vitamin D. However, clinical manifestations of most vitamin deficiencies are usually subtle or undetected in this population. Testing for circulating levels is not undertaken for most vitamins except folate, B12, and 25-hydroxyvitamin D because assays may not be available or may be costly to perform and do not always correlate with body stores. The last systematic review through 2016 was performed for the Kidney Disease Outcome Quality Initiative (KDOQI) 2020 Nutrition Guideline update, so this article summarizes the more recent evidence. We review the use of vitamins supplementation in the CKD population. To date there have been no randomized trials to support the benefits of any vitamin supplementation for kidney, cardiovascular, or patient-centered outcomes. The decision to supplement water-soluble vitamins should be individualized, taking account the patient's dietary intake, nutritional status, risk of vitamins deficiency/insufficiency, CKD stage, comorbid status, and dialysis loss. Nutritional vitamin D deficiency should be corrected, but the supplementation dose and formulation need to be personalized, taking into consideration the degree of 25-hydroxyvitamin D deficiency, parathyroid hormone levels, CKD stage, and local formulation. Routine supplementation of vitamins A and E is not supported due to potential toxicity. Although more trial data are required to elucidate the roles of vitamin supplementation, all patients with CKD should undergo periodic assessment of dietary intake and aim to receive various vitamins through natural food sources and a healthy eating pattern that includes vitamin-dense foods.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Wang AY, Elsurer Afsar R, Sussman-Dabach EJ, et al. Vitamin Supplement Use in Patients With CKD: Worth the Pill Burden? Am J Kidney Dis. 2023. PMID: 37879527. doi:10.1053/j.ajkd.2023.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。